No Data
No Data
Eye Health Supplements Global Outlook & Forecasts 2024-2029 With Amway, Bausch Health Companies, Nature's Bounty, Vitabiotics, and ZeaVision Leading the $3.28 Billion Market - ResearchAndMarkets.com
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $9
Jefferies analyst Glen Santangelo maintains $Bausch Health(BHC.US)$ with a buy rating, and adjusts the target price from $13 to $9.According to TipRanks data, the analyst has a success rate of 54.5%
Bausch + Lomb Shares Up in Premarket Amid Sale Consideration
Bausch + Lomb Reportedly Exploring Sale to Handle Bausch Health Spinoff
Here's Why Bausch Health (BHC) Is a Strong Momentum Stock
Bausch Health Companies Says Cabtreo Gets Health Canada Approval